Brett O’Brien
PhD-qualified scientific leader with more than 15 years of R and D experience across medical diagnostics, biotechnology, pharmaceuticals and academia, including eight years leading scientific teams. Principal R and D Scientist and Group Lead with 11 direct reports and accountability for team performance, capability development, resource planning and delivery across complex diagnostic-biomarker programmes. Combines assay-development […]
Jeffrey M. Skredenske
Accomplished expert in biologics (upstream and downstream) and bioconjugation with deep experience in process development, manufacturing, and process validation. Demonstrated success leading cross-functional teams and managing strategic CDMO partnerships to advance monoclonal antibody and antibody-drug conjugate programs through early- and late-phase clinical trials and IND and BLA preparation and submission. Strong background in high-impact project […]